Dr Panagiotis Kanavos

This course will be led by Professor Jaime Caro.

This course is available on the Executive MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences and Executive MSc in Health Economics, Policy and Management. This course is not available as an outside option.

Health Technology Assessment a multidisciplinary process that summarises information about the medical, social, economic, and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, and robust manner. Health Technology Assessment differs in its governance, data and evidence requirements, assessment methods, and operational arrangements across different settings and contexts. This course is aimed at introducing the key principles of Health Technology Assessment, its operational modalities, the different models of value assessment and how they link to decision-making.

Outline of the course is included below:

1. The role of Health Technology Assessment in health care decision making

2. Models of Health Technology Assessment and their application in different jurisdictions - a comparative perspective

3. Governance issues (position in health care decision-making, topic selection, assessment process, stakeholder involvement)

4. Data and evidence requirements for value assessment

5. Health Technology Assessment and value assessment: focus on clinical benefit assessment

6. Health Technology Assessment and value assessment: focus on clinical-cost-effectiveness

7. Assessment methods in Health Technology Assessment

8. Explaining similarities and differences in Health Technology Assessment recommendations – a toolkit

9. The role of multiple criteria decision analysis in value assessment

10. Beyond Health Technology Assessment: links to risk-sharing and special purchasing arrangements

This course will be delivered as a combination lectures and seminars, totalling a minimum of 20 hours. As well as access to lectures, students will work in small groups to present topics and lead discussion in seminars. Students will also take part in discussion on case studies set by the course lead.

A selection of multiple choice and open-ended questions to test extent of knowledge and understanding of syllabus

Chalkidou, K., Tunis, S., Lopert, R., Rochaix, L., Sawicki, P. T., Nasser, M., & Xerri, B. (2009). Comparative Effectiveness Research and Evidence Based Health Policy: Experience from Four Countries. Milbank Quarterly, 87(2), 339-367.

Banta, H. D., & Luce, B. R. (1993). Health care technology and its assessment: an international perspective.

Drummond, M. F., Schwartz, J. S., Jönsson, B., Luce, B. R., Neumann, P. J., Siebert, U., & Sullivan, S. D. (2008). Key principles for the improved conduct of health technology assessments for resource allocation decisions. International journal of technology assessment in health care, 24(03), 244-258.

Sorenson, C., Drummond, M., & Kanavos, P. (2008). Ensuring value for money in health care: the role of health technology assessment in the European Union (No. 11). WHO Regional Office Europe.

Sorenson, C. (2010). Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison. Issue Brief (Commonwealth Fund), 91, 1-14.

Research project (100%) in the ST.